You have said repeatedly that NR won't let go of I
Post# of 72440
a deal that brings in upfront monies to IPIX of $30MM+ or some such number?
a beginning of royalty revenues?
a successful pill for either B or K that is approved by FDA/EMA for human trial?
days of XX million volume trade days that are not just wash sales?
uplisting to NASDQ?
It seems with so many easy targets NR would not hang around this long with a company that obviously isn't going to cave to their usual game plan
Or do they know that sooner or later they will be able to cut most of their losses, even if it takes a year or more, and only then move on to greener pastures?